Which hedge funds own ONCY? ONCOLYTICS BIOTECH INC, Q2 2026 13F holders
7 tracked hedge funds disclosed a position in ONCY (ONCOLYTICS BIOTECH INC) in their Q2 2026 13F filings, worth $1.0m in total. The largest holder by portfolio weight is Connective Capital Management, LLC at 0.1% of its book. 4 opened a new position this quarter: Connective Capital Management, LLC, Catalyst Funds Management Pty Ltd, Y-Intercept (Hong Kong) Ltd, Millennium Management LLC.
- 7
- Holders Tracked managers whose filing for the quarter reports a long equity position in the security.
- 4
- New this quarter Holders whose previous filing (at most two quarters earlier) did not report the security.
- 0
- Exited this quarter Tracked managers whose previous filing reported the security and whose filing for the quarter does not.
- $229k
- Inflow, new holders Combined value of the positions the new holders reported for the quarter.
- $0
- Outflow, exits Combined value the exiting managers reported for the security in their previous filing.
- $1.0m
- Combined value Sum of the holders' reported positions in the security.
- 0.6%
- Share of managers holding Holders as a share of tracked managers filing for that quarter. Comparable across the 2024 coverage expansion, where the raw holder count is not.
Holders, Q2 2026
| Connective Capital Management, LLC Hedge fund | 0.1% | – | new |
| Catalyst Funds Management Pty Ltd Hedge fund | 0.0% | – | new |
| Marshall Wace, LLP Hedge fund | 0.0% | −13% | reduced |
| Y-Intercept (Hong Kong) Ltd Hedge fund | 0.0% | – | new |
| Renaissance Technologies LLC Hedge fund | 0.0% | −91% | reduced |
| Citadel Advisors LLC Hedge fund | 0.0% | +10% | added |
| Millennium Management LLC Hedge fund | 0.0% | – | new |
Ownership over time
Who discovered ONCY first? Beta
| Anson Funds Management LP | Q3 2023 | −1.3 pts |
Split-adjusted quarter-end prices, excluding dividends. They describe the stock while each manager held it, not the return it earned.